TRILACICLIB | TRILACICLIB | ATC V03AF12
ANTINEOPLASTIC CDK4 AND CDK6 KINASE INHIBITOR TO DECREASE THE INCIDENCE OF CHEMOTHERAPY-INDUCED MYELOSUPPRESSION | INTRAVENOUS | VD 1130 LITER Cl 158 LITER / HOUR HT 14 HOUR | CDK4 CDK6 | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |